Gilead Sciences GILD
NASDAQ GILD
$149.05 -2.23 (-1.47%)
At close: Sep 30, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Total Current Liabilities (2009 - 2026)

Updated

Gilead Sciences (GILD) posted Total Current Liabilities of $11.02 billion for Q2 2026, down 1.5% from $11.19 billion a year earlier but up 16.3% from the prior quarter.

Analysis

Gilead Sciences (GILD) Total Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Gilead Sciences' Total Current Liabilities came in at $11.81 billion, down 1.6% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
  • In prior years, Gilead Sciences' Total Current Liabilities was $12 billion in FY2024 (+6.4%), $11.28 billion in FY2023 (+0.4%), $11.24 billion in FY2022 (-3.2%) and $11.61 billion in FY2021 (+1.9%).
  • Quarterly Total Current Liabilities has run from a low of $8.56 billion in Q1 2022 to a high of $13.96 billion in Q2 2023 over five years.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last three quarters, with an average decline of 2.3% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2023, with growth of 51.5%; the weakest was Q1 2026, with a decline of 23.2%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $9.48 billion (Q1 2026), $11.81 billion (Q4 2025) and $12.3 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 18.66 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.02 Bn
Mar 31, 2026 9.48 Bn
Dec 31, 2025 11.81 Bn
Sep 30, 2025 12.30 Bn
Jun 30, 2025 11.19 Bn
Mar 31, 2025 12.34 Bn
Dec 31, 2024 12.00 Bn
Sep 30, 2024 11.73 Bn
Jun 30, 2024 10.78 Bn
Mar 31, 2024 13.02 Bn
Dec 31, 2023 11.28 Bn
Sep 30, 2023 11.95 Bn
Jun 30, 2023 13.96 Bn
Mar 31, 2023 10.53 Bn
Dec 31, 2022 11.24 Bn
Sep 30, 2022 10.42 Bn
Jun 30, 2022 9.22 Bn
Mar 31, 2022 8.56 Bn
Dec 31, 2021 11.61 Bn
Sep 30, 2021 10.25 Bn
API Access

Gilead Sciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GILD&period=max&api_key=YOUR_API_KEY